Since the potential clinical value of GGT5 in predicting the outcomes of gastric cancer patients was demonstrated, we established a nomogram including GGT5 and other clinical characteristics (age, primary therapy outcome, residual tumor, and pathologic stage) according to the results of the univariate and multivariate Cox regressions. This evidence concerns the gene GGT5 and neoplasm.